Proteomics in discovery of hepatocellular carcinoma biomarkers

被引:0
|
作者
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
关键词
proteomics; biomarker; hepatocellular carcinoma;
D O I
10.1007/s11670-007-0159-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [21] Proteomics-related biomarkers for HBV-associated hepatocellular carcinoma: current status and future prospects
    Feng, Huixing
    Zhang, Jianhua
    Tan, Jane Y. L.
    Sadrolodabaee, Laleh
    Chen, Wei Ning
    FUTURE VIROLOGY, 2012, 7 (02) : 161 - 171
  • [22] Role of Proteomics in the Discovery of Autism Biomarkers
    AL-Ayadhi, Laila
    Halepoto, Dost Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (02): : 137 - 143
  • [23] Secretome proteomics for discovery of cancer biomarkers
    Makridakis, Manousos
    Vlahou, Antonia
    JOURNAL OF PROTEOMICS, 2010, 73 (12) : 2291 - 2305
  • [24] Proteomics efforts for hepatocellular carcinoma drug development
    Dongling Jia
    Zongtai Jiang
    Minhui Cui
    Xianting Ding
    Clinical Cancer Bulletin, 3 (1):
  • [25] Proteomics for the early detection and treatment of hepatocellular carcinoma
    Feng, J. T.
    Shang, S.
    Beretta, L.
    ONCOGENE, 2006, 25 (27) : 3810 - 3817
  • [26] A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma
    Steel, LF
    Shumpert, D
    Trotter, M
    Seeholzer, SH
    Evans, AA
    London, WT
    Dwek, R
    Block, TM
    PROTEOMICS, 2003, 3 (05) : 601 - 609
  • [27] Proteomics for the early detection and treatment of hepatocellular carcinoma
    J T Feng
    S Shang
    L Beretta
    Oncogene, 2006, 25 : 3810 - 3817
  • [28] Biomarkers for the early diagnosis of hepatocellular carcinoma
    Nobuhiro Tsuchiya
    Yu Sawada
    Itaru Endo
    Keigo Saito
    Yasushi Uemura
    Tetsuya Nakatsura
    World Journal of Gastroenterology, 2015, (37) : 10573 - 10583
  • [29] Discovery of putative pancreatic cancer biomarkers using subcellular proteomics
    McKinney, Kimberly Q.
    Lee, Yong-Yook
    Choi, Hyun-Su
    Groseclose, Gale
    Iannitti, David A.
    Martinie, John B.
    Russo, Mark W.
    Lundgren, Deborah H.
    Han, David K.
    Bonkovsky, Herbert L.
    Hwang, Sun-Il
    JOURNAL OF PROTEOMICS, 2011, 74 (01) : 79 - 88
  • [30] Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
    Debes, Jose D.
    Romagnoli, Pablo A.
    Prieto, Jhon
    Arrese, Marco
    Mattos, Angelo Z.
    Boonstra, Andre
    CANCERS, 2021, 13 (07)